Preoperative CRP(−)/CEA(−)/CA19-9(−)/non-T4 in Stage III Colorectal Cancer Is Favorable Risk for Recurrence

Preoperative CRP(−)/CEA(−)/CA19-9(−)/non-T4 in Stage III Colorectal Cancer Is Favorable Risk for Recurrence

Objectives: We evaluated the prognostic impact of a novel C-reactive protein (CRP) cut-off value (0.6 mg/dl) and carcinoembryonic antigen (CEA)/carbohydrate antigen 19-9 (CA19-9) in stage II/III colorectal cancer. Methods: Four hundred ninety-eight patients with stage II (n = 275) or stage III (n =...

Full description

Bibliographic Details
Main Authors: Mitsunori Ushigome, Hideaki Shimada, Tomoaki Kaneko, Yasuyuki Miura, Yasuo Nagashima, Takayuki Suzuki, Satoru Kagami, Akiharu Kurihara, Kimihiko Funahashi
Format: Article
Language:English
Published: The Japan Society of Coloproctology 2022-10-01
Series:Journal of the Anus, Rectum and Colon
Subjects:
crp
cea
ca19-9
colorectal cancer
relapse-free survival
Online Access:https://www.jstage.jst.go.jp/article/jarc/6/4/6_2022-010/_pdf/-char/en

Similar Items

Similar Items